HomeCompareDTARF vs PFE

DTARF vs PFE: Dividend Comparison 2026

DTARF yields 1408.45% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DTARF wins by $396181116.90M in total portfolio value
10 years
DTARF
DTARF
● Live price
1408.45%
Share price
$0.14
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$396181116.95M
Annual income
$347,628,612,125,698.30
Full DTARF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — DTARF vs PFE

📍 DTARF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDTARFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DTARF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DTARF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DTARF
Annual income on $10K today (after 15% tax)
$119,718.31/yr
After 10yr DRIP, annual income (after tax)
$295,484,320,306,843.56/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, DTARF beats the other by $295,484,320,284,523.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DTARF + PFE for your $10,000?

DTARF: 50%PFE: 50%
100% PFE50/50100% DTARF
Portfolio after 10yr
$198090558.50M
Annual income
$173,814,306,075,978.53/yr
Blended yield
87.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

DTARF
No analyst data
Altman Z
-89.5
Piotroski
0/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DTARF buys
0
PFE buys
0
No recent congressional trades found for DTARF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDTARFPFE
Forward yield1408.45%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$396181116.95M$49.6K
Annual income after 10y$347,628,612,125,698.30$26,258.71
Total dividends collected$392623552.61M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DTARF vs PFE ($10,000, DRIP)

YearDTARF PortfolioDTARF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$151,545$140,845.07$9,153$693.39+$142.4KDTARF
2$2,156,955$1,994,801.51$8,593$849.25+$2.15MDTARF
3$28,842,699$26,534,757.71$8,336$1,066.78+$28.83MDTARF
4$362,470,620$331,608,932.15$8,437$1,384.80+$362.46MDTARF
5$4,282,591,462$3,894,747,898.48$9,013$1,875.40+$4282.58MDTARF
6$47,588,408,428$43,006,035,563.10$10,306$2,680.72+$47588.40MDTARF
7$497,541,651,942$446,622,054,924.38$12,820$4,101.38+$497541.64MDTARF
8$4,896,368,656,645$4,363,999,089,067.01$17,673$6,826.70+$4896368.64MDTARF
9$45,376,172,736,896$40,137,058,274,285.76$27,543$12,591.86+$45376172.71MDTARF
10$396,181,116,954,177$347,628,612,125,698.30$49,560$26,258.71+$396181116.90MDTARF

DTARF vs PFE: Complete Analysis 2026

DTARFStock

Delta Resources Limited, an exploration company, engages in the acquisition, exploration, and development of gold and base metal projects in Canada. It has an agreement to acquire a 100% interest in the Delta-1/Eureka project, which consists of 245 mining claims totaling an area of 4,495 hectares located in the Thunder Bay district of Ontario; and the Delta-2 project comprising 237 claims covering an area of 12,650 hectares located in the Chibougamau Mining district of Quebec. The company also holds an option agreement to acquire the Dollier property that consists of 40 claims covering an area of 2,228 hectares located in Chibougamau, Quebec. The company was formerly known as Golden Hope Mines Limited and changed its name to Delta Resources Limited in July 2019. Delta Resources Limited was incorporated in 1946 and is based in Kingston, Canada.

Full DTARF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this DTARF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DTARF vs SCHDDTARF vs JEPIDTARF vs ODTARF vs KODTARF vs MAINDTARF vs JNJDTARF vs MRKDTARF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.